Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
BlackBerry-maker Research In Motion Ltd., (RIMM) is set to launch cheaper smartphone called BlackBerry Curve 9310 at Verizon Wireless, which is a part of Verizon Communication Inc. (VZ - Analyst Report).
The new BlackBerry 7- based smartphone is a slim user-friendly handset featuring all social network applications and the popular BBM messenger. It also features a 3.2 MP camera and the popular BlackBerry keypad. Moreover, the VZ Navigator, which is installed in the handset, will enable users to locate directions.
The new smartphone is priced at $49.99 and will be available from July 12 at Verizon Wireless stores along with a two-year wireless service contract. The service plan starts from $80 and includes unlimited talk and text messaging and 300 MB of data.
Research In Motion, once a dominant player in the wireless e-mail sector, is currently facing significant market share loss in the high-end smartphone market to Google Inc’.s (GOOG - Analyst Report) Android-based devices and Apple Inc’.s (AAPL - Analyst Report) smartphones. As a result, the company is currently focusing on the low-end smartphone market just like Nokia Corporation (NOK - Analyst Report), which has also taken a beating due to the prominence of Apple’s iPhones and Google’s Android-based smartphones. Moreover, the delayed launch of BlackBerry 10- based smartphones has also forced Research In Motion to change its strategy and concentrate on the low-end smartphone market, thereby keeping the handset manufacturer afloat till the launch of powerful BB10 powered handsets.
We are maintaining our long-term Neutral recommendation on Research In Motion. Currently, it has a Zacks #4 Rank, implying a short-term Sell rating on the stock.
Get the full Analyst Report on GOOG - FREE
Get the full Analyst Report on AAPL - FREE
Get the full Analyst Report on NOK - FREE
Get the full Analyst Report on VZ - FREE